U.S. Oil and Gas Stock News

NYSE:G
NYSE:GProfessional Services

Genpact’s Databricks ‘Rising Star’ Status and AI Center Expansion Might Change The Case For Investing In Genpact (G)

Genpact recently declared a third-quarter 2026 cash dividend of US$0.1875 per share and earlier partnered with Nestlé Business Solutions to build a new Global Capability Center in Hyderabad, India, focused on AI-driven process transformation. Genpact was also named the sole Rising Star in ISG’s 2026 Databricks Ecosystem Partners report, underscoring its growing role in AI-ready data and agentic AI solutions for large enterprises. We’ll now examine how Genpact’s ISG Rising Star recognition in...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Intellia Therapeutics Stock And 2 High Growth Shares With Strong Balance Sheets

With inflation, energy costs and interest rates all under close watch, many investors are looking for companies that pair solid balance sheets with the prospect of faster earnings growth. That is exactly what the Healthy high growth potential screener targets. It focuses on stocks that analysts expect to deliver stronger earnings over the next 3 years while still meeting basic financial health checks. In this article, you will see 3 of the most interesting stocks from this screener and how...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

FuboTV (FUBO) Stock May Be Undervalued Despite A 97% 5 Year Slide

FuboTV stock has given investors a steeply negative 5 year return, while the latest valuation checks still suggest the shares screen cheap relative to the fundamentals that are being measured. FuboTV has declined 97.1% over the past 5 years, which means any valuation case now rests on whether the remaining business can justify even the current share price. The appointment of former Disney+ president Alisa Bowen as CEO may support expectations for a clearer growth plan and operating...
NYSE:ATEN
NYSE:ATENSoftware

A10 Networks (ATEN) Stock Trades At A Premium Despite A 238% Run

A10 Networks stock has delivered a strong 237.6% total return over the past 5 years, yet current checks suggest the shares now trade at a premium to an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and to common market multiples. A 237.6% return over 5 years puts A10 Networks firmly in the group of stocks where past gains raise the bar for what counts as good value today. Expectations for continued cash flow generation from A10 Networks' networking and security...
NYSE:JBL
NYSE:JBLElectronic

Is Jabil (JBL) Undervalued After Its AI Logistics Hub And $1.5b Buyback?

Jabil (JBL) has drawn fresh attention after approving a share repurchase program of up to US$1.5b and inaugurating an AI-enabled logistics hub in Penang, while also affirming a quarterly dividend of US$0.08 per share. See our latest analysis for Jabil. At a share price of US$305.91, Jabil has seen its 30 day share price return decline 17.74%, even though the year to date share price return is 27.26% and the 5 year total shareholder return is 440.92%. This suggests that longer term holders...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase (JPM) CEO Jamie Dimon Warns UK PM On Bank Windfall Taxes

Jamie Dimon, CEO of JPMorgan Chase, publicly warned new UK Prime Minister Andy Burnham about potential windfall taxes on banks. Dimon cautioned against higher bank surcharges and outlined possible negative effects on the banking sector and UK economic growth. The comments spotlight growing concern among large banks over the political and regulatory climate in a key international market. JPMorgan Chase, traded as NYSE:JPM, is coming under fresh attention after its CEO weighed in directly on...
NYSE:GE
NYSE:GEAerospace & Defense

Did GE’s (GE) Hybrid-Electric Milestone and New Engine Deals Just Shift Its Aerospace Investment Narrative?

General Electric’s aerospace division recently reported higher second-quarter 2026 revenue of US$13.35 billion and net income of US$2.37 billion, alongside completing a US$2.01 billion share buyback and securing new GEnx-1B engine deals with Philippine Airlines and AerCap. At the same time, GE Aerospace advanced hybrid-electric propulsion with a high-altitude test flight above 30,000 feet and deepened customer ties through large engine orders and collaborations, underscoring how innovation...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle (ORCL) Following Wisconsin Ruling, Is The AI Data Center Story Still Undervalued?

Oracle (ORCL) is back on investors' radar after Wisconsin regulators upheld rules that could require more than US$7b in financial guarantees for the company’s planned AI focused data center project. See our latest analysis for Oracle. Oracle’s share price has come under sustained pressure, with the stock down 34.1% on a 30 day share price return basis and 38.0% year to date, even though the 5 year total shareholder return of 47.8% remains positive. This suggests long term holders have still...
NYSE:F
NYSE:FAuto

Ford (F) Stock Looks Fully Valued After Its 35% Five Year Rise

Ford Motor stock has returned 34.5% over the past five years, yet its current valuation picture is pulled in two directions, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples suggest the shares may still be priced reasonably against earnings and sales. Over the last 5 years, Ford Motor has delivered a 34.5% return, which puts recent pricing in the context of a steadily compounding gain rather than a sudden spike. Profitability in high...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

How Investors May Respond To Cimpress (CMPR) Upgraded Earnings Outlook And Bullish Analyst Sentiment

Recently, analysts highlighted Cimpress as a strong growth stock, pointing to significantly above-industry expectations for earnings per share growth and positive revisions to earnings estimates. This renewed confidence in Cimpress' earnings trajectory underscores how analyst sentiment can materially influence the perceived quality and durability of its profit outlook. Next, we will examine how these upgraded earnings expectations and bullish analyst commentary might influence Cimpress'...
NYSE:AORT
NYSE:AORTMedical Equipment

Artivion (AORT) Cuts Guidance Following AMDS Slower Adoption, Is It Still Below Fair Value?

Artivion (AORT) is back in focus after the company cut its full year guidance, citing slower than expected adoption of its AMDS product, despite reporting 12% non GAAP constant currency revenue growth in Q1 2026. See our latest analysis for Artivion. At a share price of $25.37, Artivion has seen a 19.73% 1 month share price return and a 5.58% 7 day share price return, although the 90 day share price return is down 30.61% and the year to date share price return is down 42.94%. The 3 year total...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Carvana (CVNA) Stock Looks Fully Valued After Its 7x Run

Carvana stock has delivered a very large 3 year return while the broader valuation checks still lean expensive, which raises the question of how much of the story is already reflected in the current share price. Over 3 years, Carvana has returned close to 7x, which puts recent short term declines into context as part of a much larger move. Recent reports of market share gains in a flat used car market may support growth expectations, while new competitors such as Bidbus could pressure...
NYSE:BG
NYSE:BGFood

3 U.S. Food Stocks That Could Benefit From New Canada Tariffs

Tariffs on Canadian dairy, lumber, vehicles, seeds, and agricultural inputs are reshaping expectations for U.S. agriculture and food production stocks. With new 50% duties affecting an estimated US$20b in imports, some companies could gain from a tilt toward domestic supply, while others face higher costs and fresh uncertainty around trade. For investors watching the U.S. Domestic Agriculture and Food Producers screener, this is a moment to reassess which businesses look better positioned and...
NYSE:BW
NYSE:BWElectrical

Is Babcock & Wilcox (BW) Rebalancing Capital Toward Debt Cuts or Signaling New Shareholder Priorities?

Babcock & Wilcox Enterprises has redeemed all US$61.4 million of its 6.50% Senior Notes due 2026 and announced a US$50 million share repurchase program, both approved in July 2026 and structured to eliminate these notes and potentially reduce its share count over time. Together, the full bond redemption and open-ended buyback plan highlight a shift in how Babcock & Wilcox Enterprises is using its balance sheet, prioritizing debt reduction alongside returning capital to shareholders. Next,...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Stock Looks Fairly Valued With Cash Flow Upside

Johnson & Johnson stock has delivered a 66.6% gain over the past 5 years, yet current checks flag a mixed picture on value, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples suggest pricing is closer to fair. A 66.6% return over 5 years signals that long term holders have already seen substantial value creation, which raises the bar for any new upside case. Ambitious growth plans in oncology and other specialty medicines can...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Veeva (VEEV) Stock May Be 34% Undervalued As It Launches Veeva EHS

Veeva Systems enters this valuation check with a share price of US$197.41 and a 5 year return that is down 39.9%, while the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside and traditional earnings multiples lean the other way. That split between an intrinsic value model suggesting the stock may be undervalued and market multiples that look rich sets up a clear tension for investors trying to work out what Veeva Systems is really worth today. Over the last 5...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom (AVGO) Stock May Be 10% Undervalued Despite AI Selloff Fears

After an extraordinary run over the past five years, Broadcom’s valuation now sits at an interesting crossroads, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggesting the stock may be pricing in less than its recent share price strength might imply. Broadcom has delivered a very large 5 year return of about 7.6x, which puts extra focus on whether current cash flow expectations still support the price. Expectations for AI related chip and...
NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

Is Certara (CERT) A Bargain Following Its NVIDIA AI Collaboration?

Certara (CERT) is back in focus after announcing a collaboration with NVIDIA to bring the BioNeMo Agent Toolkit into its open integrated AI platform for drug development and biosimulation clients. See our latest analysis for Certara. Certara's latest AI collaboration comes after a sharp 30 day share price return of 25.27%, although the year to date share price return is down 20.59% and the 1 year total shareholder return has fallen 31.56%. This points to improving short term momentum against...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Is Zscaler (ZS) A Bargain On Growing Zero Trust Adoption?

Zscaler (ZS) is back in focus after appointing seasoned marketer Nikhil Mehrotra as Senior Director of Marketing, along with reports that more than 700 enterprises are using its Zero Trust Everywhere platform. See our latest analysis for Zscaler. Recent marketing hires and expanding Zero Trust Everywhere adoption come as Zscaler’s share price sits at US$149.82, with a 30 day share price return of 20.00% but a 1 year total shareholder return that has fallen 48.06%. This suggests improving...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple (AAPL) Faces Fresh EU Pressure As US Lawmakers Push White House Response

A bipartisan group of US lawmakers has urged the White House to push back against European Union tech rules, including the Digital Markets Act, that they argue unfairly target Apple and other large US platforms. The request, focused on what lawmakers describe as discrimination against US companies, raises the prospect of trade friction between Washington and Brussels. The developments could influence how Apple structures parts of its business in Europe, including app distribution and...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Names Commercial HVAC Chief, Where Does Fair Value Sit?

Modine Manufacturing (MOD) is drawing fresh attention after the company appointed Michael Mahan as President of its newly formed Commercial HVAC segment, a move that could influence how investors view this business. See our latest analysis for Modine Manufacturing. Modine Manufacturing’s share price has eased in the short term, with a 1-day share price return of 0.64% lower and a 30-day share price return of 23.37% lower. However, its year-to-date share price return of 61.84% and 1-year total...
NYSE:PG
NYSE:PGHousehold Products

Procter & Gamble (PG) Expands Egypt Manufacturing To Build Its Gulf And Africa Hub

Procter & Gamble (NYSE:PG) agreed to expand its manufacturing and export operations in Egypt following discussions with the country’s Investment Minister. The company plans to use Egypt as a production and export base for Gulf and African markets. The initiative aligns with broader themes of regional diversification and supply chain adjustment across consumer goods companies. Procter & Gamble, a global consumer products company behind household and personal care brands, is looking to...
NYSE:BALL
NYSE:BALLPackaging

Ball (BALL) Stock Looks Below Fair Value With Weak Returns and Solid Earnings

Ball stock is trading at US$62.25 after a period where the share price has risen in the shorter term but is still down 18.1% over five years, while both a Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently suggest the shares may be undervalued. Over the last five years Ball has delivered a total return that declined 18.1%, which means long term holders have not yet seen the benefit that recent gains suggest. Expectations for continued earnings strength...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE) Stock Seems Fairly Priced As Oncology Approvals Build

Pfizer stock has clawed back some ground over the past year but is still down sharply over five years, and the current valuation checks point to something closer to a middle ground than a clear bargain or an obvious premium. Pfizer shares have declined 23.5% over the past five years, which leaves long term holders with a weak overall return and raises the question of whether today’s price now roughly reflects that reset. Regulatory wins in oncology and weight loss treatments may support...